Crossmark

Re-evaluating hereditary breast and ovarian cancer risk: clinical impact of updated multigene panel sequencing and genetic counseling

Published Online: 2026-03-27

Authors

Gislinge, Julie Isabelle Plougmann

Byrjalsen, Anna

Naver, Klara Vinsand

Clausen, Helle Vibeke

Ravn, Pernille

Petersen, Kresten Rubeck

Wadt, Karin A. W.
Funding

Funding for this research was provided by:

National Hospital
License Information

Text and Data Mining valid from 2026-03-27

Version of Record valid from 2026-03-27
More Information

Article History

Received: 26 August 2025

Accepted: 16 March 2026

First Online: 27 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current